Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant

NCT05203965 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Familial Alcoholism Vulnerability

Interventions

DRUG: Mavoglurant (AFQ056)
DRUG: Placebo

Sponsor

Yale University

Collaborators

[object Object]